ePRO Brightline-3 (1403-0006) app for iPhone and iPad
Boehringer Ingelheim ePRO Brightline-3 is intended to collect patient reported outcomes relating to a clinical trial (Trial Brightline-3 - 1403-0006). Patients must be given accounts by a participating site in order to log in to the app.